First Time Loading...

Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 177.8 SEK -0.73% Market Closed
Updated: May 21, 2024

Intrinsic Value

Biotage AB engages in the provision of separation and synthesis technology solutions. [ Read More ]

The intrinsic value of one BIOT stock under the Base Case scenario is 178.72 SEK. Compared to the current market price of 177.8 SEK, Biotage AB is Undervalued by 1%.

Key Points:
BIOT Intrinsic Value
Base Case
178.72 SEK
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biotage AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BIOT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biotage AB

Provide an overview of the primary business activities
of Biotage AB.

What unique competitive advantages
does Biotage AB hold over its rivals?

What risks and challenges
does Biotage AB face in the near future?

Summarize the latest earnings call
of Biotage AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biotage AB.

Provide P/S
for Biotage AB.

Provide P/E
for Biotage AB.

Provide P/OCF
for Biotage AB.

Provide P/FCFE
for Biotage AB.

Provide P/B
for Biotage AB.

Provide EV/S
for Biotage AB.

Provide EV/GP
for Biotage AB.

Provide EV/EBITDA
for Biotage AB.

Provide EV/EBIT
for Biotage AB.

Provide EV/OCF
for Biotage AB.

Provide EV/FCFF
for Biotage AB.

Provide EV/IC
for Biotage AB.

Show me price targets
for Biotage AB made by professional analysts.

What are the Revenue projections
for Biotage AB?

How accurate were the past Revenue estimates
for Biotage AB?

What are the Net Income projections
for Biotage AB?

How accurate were the past Net Income estimates
for Biotage AB?

What are the EPS projections
for Biotage AB?

How accurate were the past EPS estimates
for Biotage AB?

What are the EBIT projections
for Biotage AB?

How accurate were the past EBIT estimates
for Biotage AB?

Compare the revenue forecasts
for Biotage AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biotage AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biotage AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biotage AB compared to its peers.

Compare the P/E ratios
of Biotage AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Biotage AB with its peers.

Analyze the financial leverage
of Biotage AB compared to its main competitors.

Show all profitability ratios
for Biotage AB.

Provide ROE
for Biotage AB.

Provide ROA
for Biotage AB.

Provide ROIC
for Biotage AB.

Provide ROCE
for Biotage AB.

Provide Gross Margin
for Biotage AB.

Provide Operating Margin
for Biotage AB.

Provide Net Margin
for Biotage AB.

Provide FCF Margin
for Biotage AB.

Show all solvency ratios
for Biotage AB.

Provide D/E Ratio
for Biotage AB.

Provide D/A Ratio
for Biotage AB.

Provide Interest Coverage Ratio
for Biotage AB.

Provide Altman Z-Score Ratio
for Biotage AB.

Provide Quick Ratio
for Biotage AB.

Provide Current Ratio
for Biotage AB.

Provide Cash Ratio
for Biotage AB.

What is the historical Revenue growth
over the last 5 years for Biotage AB?

What is the historical Net Income growth
over the last 5 years for Biotage AB?

What is the current Free Cash Flow
of Biotage AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biotage AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biotage AB

Current Assets 1.5B
Cash & Short-Term Investments 683m
Receivables 364m
Other Current Assets 443m
Non-Current Assets 3.7B
Long-Term Investments 25m
PP&E 292m
Intangibles 3.3B
Other Non-Current Assets 30m
Current Liabilities 691m
Accounts Payable 59m
Other Current Liabilities 632m
Non-Current Liabilities 567m
Long-Term Debt 224m
Other Non-Current Liabilities 343m
Efficiency

Earnings Waterfall
Biotage AB

Revenue
2B SEK
Cost of Revenue
-749m SEK
Gross Profit
1.2B SEK
Operating Expenses
-905m SEK
Operating Income
327m SEK
Other Expenses
-91m SEK
Net Income
236m SEK

Free Cash Flow Analysis
Biotage AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BIOT Profitability Score
Profitability Due Diligence

Biotage AB's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Operating Income
61/100
Profitability
Score

Biotage AB's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

BIOT Solvency Score
Solvency Due Diligence

Biotage AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Negative Net Debt
81/100
Solvency
Score

Biotage AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOT Price Targets Summary
Biotage AB

Wall Street analysts forecast BIOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOT is 209.1 SEK with a low forecast of 161.6 SEK and a high forecast of 273 SEK.

Lowest
Price Target
161.6 SEK
9% Downside
Average
Price Target
209.1 SEK
18% Upside
Highest
Price Target
273 SEK
54% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Biotage AB

Shareholder Return

BIOT Price
Biotage AB

1M 1M
+11%
6M 6M
+45%
1Y 1Y
+19%
3Y 3Y
-1%
5Y 5Y
+51%
10Y 10Y
+1 688%
Annual Price Range
177.8
52w Low
86.45
52w High
186.3
Price Metrics
Average Annual Return 16.58%
Standard Deviation of Annual Returns 43.44%
Max Drawdown -70%
Shares Statistics
Market Capitalization 14.2B SEK
Shares Outstanding 79 348 690
Percentage of Shares Shorted
N/A

BIOT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biotage AB Logo
Biotage AB

Country

Sweden

Industry

Life Sciences Tools & Services

Market Cap

14.2B SEK

Dividend Yield

0.9%

Description

Biotage AB engages in the provision of separation and synthesis technology solutions. The company is headquartered in Uppsala, Uppsala and currently employs 497 full-time employees. The company went IPO on 2000-06-30. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The firm offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.

Contact

UPPSALA
Uppsala
Vimpelgatan 5
+4618565900.0
http://www.biotage.com/

IPO

2000-06-30

Employees

497

Officers

Interim CEO, President & Director
Mr. Torben Jorgensen B.Sc.
Chief Financial Officer
Mr. Andrew Kellett
Executive Vice President of Operations
Mr. Anders Wikstrom BSc, CS
EVP of Global Marketing
Raffaella Bombarda
Chief Human Resources & Sustainability Officer
Ms. Petra Duprez
President of Americas & Chief/Head of Americas
Mr. Scott Carr
Show More
Chief Auditor
Mr. Jonas Stahlberg
Executive Vice President of Business Development
Mr. Olof Nord
President of International - EMEA and APAC
Mr. Andreas Juhlin
Executive Vice President of IT & Digitalization
Mr. Magnus Nordstedt
Show Less

See Also

Discover More
What is the Intrinsic Value of one BIOT stock?

The intrinsic value of one BIOT stock under the Base Case scenario is 178.72 SEK.

Is BIOT stock undervalued or overvalued?

Compared to the current market price of 177.8 SEK, Biotage AB is Undervalued by 1%.